Fri, 28 Apr 2017 14:52 GMTWe'll sell all of our CAA shares as the stock is outside the portfolio's parameters.
Fri, 28 Apr 2017 12:00 GMTStephen “Sarge” Guilfoyle thinks SiriusXM Holdings sounds good around this level.
Thu, 27 Apr 2017 11:35 GMTSonus Networks posted less disappointed than expected earnings.
Wed, 26 Apr 2017 14:48 GMTPlus, comments on Amplify Snack Brands in light of Pepsi's results.
Tue, 25 Apr 2017 12:00 GMTStephen "Sarge" Guilfoyle lays out out the argument that investors may find a winner in Hudson Technologies.
Mon, 24 Apr 2017 21:17 GMTWe exited one position and downgraded another as earnings season heated up.
Fri, 21 Apr 2017 12:00 GMT'Sarge' Guilfoyle says that if it's possible to sniff out when a beaten-down stock can make a positive change, Avon could be it.
Wed, 19 Apr 2017 14:27 GMTCompany commentary this morning adds layer of uncertainty, which warrants being extra cautious.
Tue, 18 Apr 2017 15:40 GMTWe are selling our holdings in Synovus Financial on today's strength. Plus, an update on TherapeuticsMD.
Tue, 18 Apr 2017 11:00 GMTStephen “Sarge” Guilfoyle is our newest contributor to Stocks Under $10. And today he has an idea for you on how to make a little lunch money.
Mon, 17 Apr 2017 20:39 GMTWe added a new name to the portfolio as the market took a breather in a shortened trading week.
Thu, 13 Apr 2017 13:38 GMTOur concern about slowing loan growth in the banking sector has led us to reduce our rating on Synovus Financial to a Three from a Two.
Wed, 12 Apr 2017 14:09 GMTA look at how current market dynamics are affecting our outlook for AXAS.
Tue, 11 Apr 2017 18:59 GMTWe'll wait to see how firm deals with FDA letter.
Tue, 11 Apr 2017 13:23 GMTWe added shares of this snack food maker to the portfolio to capitalize on the shifting consumer preference for foods that are good for you.
Tue, 11 Apr 2017 12:56 GMTAmplify Snacks is a stealth stock with a lot of potential.
Mon, 10 Apr 2017 20:18 GMTChris Versace runs down the portfolio.
Mon, 10 Apr 2017 13:08 GMTThe company received a letter from the Food and Drug Administration involving deficiencies of an application for a key drug candidate.
Fri, 07 Apr 2017 14:08 GMTOur two homebuilding-related stocks depend on the health of consumers.
Thu, 06 Apr 2017 16:30 GMTThe current wave includes our new position, USA Technologies.